Skip to content
10-Q

Quarterly Report

Monopar Therapeutics MNPR

0001437749-25-026042

← back to feed
Filed
Aug 12, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Jul 31, 2025 6.17M sh
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$6.74M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$3.33M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $39.5M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $45.82M
Stockholders Equity Q2 2025 · Jun 30, 2025 $52.2M
Stockholders Equity Q2 2025 · Mar 31, 2025 $53.59M
Stockholders Equity Q2 2025 · Dec 31, 2024 $55.04M
Stockholders Equity restated Q2 2025 · Jun 30, 2024 $6.09M
Stockholders Equity restated Q2 2025 · Mar 31, 2024 $7.48M
Stockholders Equity Q2 2025 · Dec 31, 2023 $5.59M
Current Liabilities Q2 2025 · Jun 30, 2025 $1.58M
Current Liabilities Q2 2025 · Dec 31, 2024 $5.25M
Total Liabilities Q2 2025 · Jun 30, 2025 $1.66M
Total Liabilities Q2 2025 · Dec 31, 2024 $5.25M
Current Assets Q2 2025 · Jun 30, 2025 $53.75M
Current Assets Q2 2025 · Dec 31, 2024 $60.29M
Total Assets Q2 2025 · Jun 30, 2025 $53.87M
Total Assets Q2 2025 · Dec 31, 2024 $60.29M
Eps Basic Q2 2025 · Jun 30, 2025 −$0.35
Eps Basic Q2 2025 · Jun 30, 2025 −$0.73
Eps Basic restated Q2 2025 · Jun 30, 2024 −$0.49
Eps Basic restated Q2 2025 · Jun 30, 2024 −$1.00
Sga Expense Q2 2025 · Jun 30, 2025 $1.5M
Sga Expense Q2 2025 · Jun 30, 2025 $3.08M
Sga Expense Q2 2025 · Jun 30, 2024 $657.81K
Sga Expense Q2 2025 · Jun 30, 2024 $1.42M
Rd Expense Q2 2025 · Jun 30, 2025 $1.73M
Rd Expense Q2 2025 · Jun 30, 2025 $3.37M
Rd Expense Q2 2025 · Jun 30, 2024 $1.13M
Rd Expense Q2 2025 · Jun 30, 2024 $2.1M
Net Income Q2 2025 · Jun 30, 2025 −$2.45M
Net Income Q2 2025 · Jun 30, 2025 −$5.08M
Net Income Q2 2025 · Mar 31, 2025 −$2.62M
Net Income Q2 2025 · Jun 30, 2024 −$1.72M
Net Income Q2 2025 · Jun 30, 2024 −$3.36M
Net Income Q2 2025 · Mar 31, 2024 −$1.64M
Operating Income Q2 2025 · Jun 30, 2025 −$3.23M
Operating Income Q2 2025 · Jun 30, 2025 −$6.46M
Operating Income Q2 2025 · Jun 30, 2024 −$1.79M
Operating Income Q2 2025 · Jun 30, 2024 −$3.51M
Revenue Q2 2025 · Jun 30, 2025 $0